Case Report: A Pancreatic Ductal Adenocarcinoma Patient With Concurrent Targetable Somatic Novel KANK1-ALK, UPP2-NTRK3 Fusion, and Pathogenetic Germline BRCA Mutation

Pancreatic ductal adenocarcinoma (PDAC) is presently one of the cancers with the worst survival rates. The current treatment options for PDAC are relatively scarce due to insufficient understanding of molecular characteristics and subtypes of PDAC. Based on next-generation sequencing (NGS), we first...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Fan, Lu, Le, Tan, Yuan, Duan, Qianqian, Lu, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521337/
https://www.ncbi.nlm.nih.gov/pubmed/34671564
http://dx.doi.org/10.3389/fonc.2021.757965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521337/
https://www.ncbi.nlm.nih.gov/pubmed/34671564
http://dx.doi.org/10.3389/fonc.2021.757965

Ejemplares similares